What Steroid Is Used for Trigger Point Injections?

The steroids most commonly injected into trigger points are corticosteroids, specifically triamcinolone, methylprednisolone, dexamethasone, and betamethasone, usually mixed with a local anesthetic like lidocaine or bupivacaine. These are the same anti-inflammatory drugs used in joint injections and other soft-tissue procedures. What makes the topic interesting is that recent evidence and professional guidelines have increasingly questioned whether adding a steroid to a trigger point injection actually helps, with multiple pain-medicine societies concluding the benefit is minimal.

The Specific Steroids and Typical Doses

A narrative review of prospective trials on trigger point injections found that the studies used triamcinolone (at concentrations like 10 mg/mL or 20 mg/mL in small volumes), methylprednisolone (typically 40 mg/mL in a quarter-milliliter dose), dexamethasone (4 mg/mL), and betamethasone (1 mL of a standard preparation).¹ In practice, clinicians tend to choose based on institutional preference, cost, and which agent they keep in stock rather than any strong evidence favoring one steroid over another for this particular use. Triamcinolone and methylprednisolone are probably the two you will encounter most often in the United States, partly because they are affordable and widely available.

The steroid is almost never injected alone. It is diluted with a local anesthetic, which serves a dual purpose: it provides immediate short-term pain relief, and it helps the solution spread through the tissue around the trigger point.² That local anesthetic also acts as a quick diagnostic check: if the pain disappears within minutes, the clinician knows the needle hit the right spot.

Why Steroids Seemed Like a Good Idea

Trigger points are small, exquisitely tender knots found within taut bands of skeletal muscle. They are a hallmark of myofascial pain syndrome, which is one of the most common causes of chronic musculoskeletal pain. The knots are thought to involve dysfunctional motor endplates where too much acetylcholine is released, locking a cluster of muscle fibers into sustained contraction.³ The chemistry around these knots includes inflammatory mediators and sensitized nerve endings, which is why the area hurts so much when pressed.

Because corticosteroids are potent anti-inflammatory agents, the reasoning was straightforward: inject the steroid directly into the inflamed tissue, calm the local chemical environment, and break the pain cycle. This logic works well in joints affected by arthritis and in conditions like plantar fasciitis, where inflammation is a primary driver. Clinicians extended the same approach to trigger points, and the practice became routine in many pain clinics. The problem is that the mechanism behind a trigger point turns out to be more complex than simple inflammation. It involves disrupted calcium signaling, impaired local blood flow, abnormal neuromuscular activity, and energy metabolism gone wrong.⁴ An anti-inflammatory drug does not address most of those problems.

What the Research Shows About Adding Steroids

This is where the story takes a turn most patients do not expect. When researchers specifically tested whether adding a corticosteroid to a trigger point injection improved outcomes compared to injecting local anesthetic alone, the results were discouraging for the steroid. A narrative review that examined four prospective studies found that three of the four demonstrated no additional benefit from adding a corticosteroid. The one study that did report improved outcomes with the steroid was limited by design flaws.¹

A joint guideline from multiple major pain-medicine societies, including the American Society of Regional Anesthesia and Pain Medicine and the American Academy of Pain Medicine, reviewed the evidence and concluded that there is “minimal benefit” for using corticosteroids in trigger point injections.⁵ That is a notably cautious statement from organizations that regularly endorse steroid injections for other musculoskeletal conditions. The implication is clear: while corticosteroids remain a standard tool in other pain procedures, their role in trigger point injections is not well supported.

A systematic review comparing corticosteroid injection to dry needling for musculoskeletal pain found very low quality evidence that there was no significant difference between the two approaches for pain or disability at short, medium, or long-term follow-up in people with myofascial pain.⁶ In other words, inserting a needle without injecting anything at all produced roughly the same result as inserting a needle and injecting a steroid.

If Steroids Do Not Help Much, Why Does the Injection Work at All?

This question has puzzled researchers for decades. Trigger point injections can provide real relief for many people, yet the substance injected may matter less than the act of needling itself. The leading theory is that the needle mechanically disrupts the contraction knot, breaking apart the cluster of locked muscle fibers and provoking a local twitch response that “resets” the neuromuscular junction. That physical disruption happens regardless of whether the syringe contains saline, local anesthetic, steroid, or nothing at all.

Trigger point injections can be performed using no injectate (dry needling) or can involve local anesthetics, botulinum toxin, or corticosteroids.⁷ Local anesthetics like lidocaine are the most common choice when something is injected, because they reduce the post-injection soreness that dry needling sometimes produces. The anesthetic also gives patients immediate feedback that the procedure worked, which can be psychologically reassuring and may contribute to a positive outcome. Botulinum toxin (Botox) is a more specialized and expensive option sometimes reserved for cases that do not respond to other treatments, though its evidence base for trigger points is also mixed.

Dry Needling Versus Trigger Point Injection for Neck Pain

The neck is one of the most common sites where trigger points cause problems, and it has been the subject of head-to-head comparisons between dry needling and trigger point injection with medication. A systematic review and meta-analysis focusing on neck pain associated with myofascial trigger points found that trigger point injection reduced pain intensity more than dry needling, with a large effect size. However, when the researchers looked at disability, pressure pain thresholds, range of motion, and depression, there was no significant difference between the two approaches.⁸

That pattern comes up repeatedly in trigger point research. The injected substance may slightly improve pain scores on a rating scale, but it does not change how well people function, how sensitive the tissue remains, or how much the neck can move. For most patients, the practical difference between having something injected and not having something injected is modest enough that the choice often comes down to comfort during and after the procedure rather than long-term outcomes. The local anesthetic does make the experience less painful, which is why many clinicians still prefer it over dry needling.

Risks of Adding a Steroid

Even if adding a steroid offered a small benefit, that advantage would need to be weighed against the steroid’s potential downsides. The same multi-society guideline that found “minimal benefit” also flagged specific adverse events associated with corticosteroid injections: increases in blood glucose, decreases in bone mineral density, and suppression of the hormonal axis that connects the brain to the adrenal glands.⁵

For someone with diabetes, even a small corticosteroid dose injected into muscle can spike blood sugar for days. For someone at risk of osteoporosis, repeated steroid injections chip away at bone density over time. And because the steroid gets absorbed into the bloodstream to some degree, the body’s own cortisol production can be temporarily suppressed, leaving a person feeling fatigued or unwell. None of these risks are dramatic after a single injection, but trigger point problems tend to be chronic, and patients often receive multiple injections over months or years. The cumulative exposure starts to matter, especially when the evidence suggests the steroid itself is not doing much for the trigger point.

There are also general contraindications to any needle-based trigger point procedure. Absolute contraindications include active skin infection over the injection site and trigger points that simply cannot be reached with a needle. Relative contraindications include bleeding disorders, use of blood thinners, a history of excessive scarring, poorly controlled psychiatric conditions, extreme needle phobia, and systemic illness that may impair healing.⁹ These apply whether or not a steroid is included.

Does Ultrasound Guidance Change the Equation?

Traditionally, trigger point injections are performed by palpation: the clinician feels for the taut band and the tender knot, inserts the needle, and either feels for a twitch response or relies on the patient’s pain response to confirm placement. But imaging guidance, particularly ultrasound, has gained attention as a way to improve accuracy. A systematic review of ultrasound-guided procedures for trigger points found some evidence, from two studies totaling 174 participants, that ultrasound guidance improved pain and function compared to blind injections. The procedures were also remarkably safe, with zero or only minimal self-limited adverse events.¹⁰

The catch is that the studies had a high risk of bias, so the results need to be taken with some caution. Still, the logic is appealing: if the needle’s mechanical effect on the trigger point matters more than what is injected, then getting the needle precisely into the right spot should improve results. Ultrasound can show the taut band and sometimes even the twitch response in real time, letting the clinician verify that the needle is in the trigger point rather than in nearby healthy tissue. For deeper muscles or patients whose anatomy makes palpation difficult, ultrasound guidance is increasingly seen as a practical upgrade.

Combining Injections With Physical Therapy

One area where the evidence is more encouraging is the combination of trigger point injections with active rehabilitation. A systematic review of trigger point injections for chronic musculoskeletal pain found that adding injections to stretching exercises improved treatment outcomes, though other therapies like ultrasound and laser added similar benefits to stretching alone.¹¹ The injection appears to create a window of reduced pain during which stretching and strengthening exercises are more tolerable and more effective.

A study of pelvic floor trigger point injections illustrated this concept with concrete numbers. Patients who received trigger point injections followed by myofascial release physical therapy had substantially better pain score improvements than those who received injections alone. About three-quarters of patients in the combined group improved by 3 or more points on a pain scale, compared to fewer than half of those who got only the injection.¹² The takeaway for anyone receiving trigger point injections, with or without a steroid, is that the injection alone is rarely the whole solution. Following up with stretching, physical therapy, or myofascial release gives the procedure its best chance of producing lasting relief.

Why Steroids Are Still Used Despite the Evidence

If the research is this lukewarm about corticosteroids in trigger point injections, you might wonder why any clinician still reaches for one. Several factors keep the practice alive. First, clinical inertia: corticosteroid injections have been a staple of pain management for decades, and old habits change slowly. Second, some clinicians suspect that certain patients with a stronger inflammatory component may benefit even if the average study participant does not. Third, the evidence base, while consistent in its direction, is composed of small studies with methodological limitations. Researchers have noted that the overall quality of evidence in this area is very low, which means the door is not firmly shut on corticosteroids; it is just hard to argue they should be a default choice.

Insurance reimbursement and coding also play a role. In some practice settings, the injection of a medication (including a steroid) is reimbursed at a different rate than dry needling or injection of anesthetic alone. These financial incentives can influence clinical decisions in ways that do not always align with the best available evidence. There is also a patient expectation factor: many people arrive at a pain clinic having been told they will get “a steroid shot,” and some clinicians find it easier to include the steroid than to explain why they are leaving it out.

What to Ask Your Clinician

If you are scheduled for a trigger point injection and want to make an informed decision, a few questions are worth raising. Ask whether the injection will include a corticosteroid and, if so, which one and why. If the clinician’s reasoning is “that is what we always use,” the evidence would support asking whether local anesthetic alone might be equally effective with fewer systemic side effects. If you have diabetes or osteoporosis, bring those conditions up specifically, because corticosteroid exposure is more consequential for you.

Ask about the plan after the injection, too. If the answer is “come back if it hurts again,” you are probably missing the rehabilitation component that makes these procedures work best. A physical therapy referral or even a home stretching program targeted at the affected muscle group can extend the benefit of the injection well beyond what the needle alone can achieve. And if you have had several rounds of trigger point injections without lasting improvement, it is reasonable to ask whether something else is going on. Trigger points can be secondary to posture problems, repetitive strain, joint dysfunction, or even stress, and addressing the underlying cause often matters more than any single injection.

Botulinum Toxin as an Alternative Injectate

Beyond steroids and local anesthetics, botulinum toxin (commonly known as Botox) is occasionally used in trigger point injections. The idea is that botulinum toxin blocks the release of acetylcholine at the neuromuscular junction, directly addressing the excessive acetylcholine release thought to sustain the contraction knot. In theory, this is more mechanism-specific than a corticosteroid, which targets inflammation rather than the neuromuscular problem itself.

In practice, botulinum toxin for trigger points remains somewhat niche. It is substantially more expensive than lidocaine or triamcinolone, it takes days to reach full effect rather than providing immediate relief, and the evidence supporting its superiority over simpler injectates is inconsistent. It tends to be reserved for refractory cases where patients have not responded to standard trigger point injections, physical therapy, and other conservative measures. Some headache specialists also use it for trigger points in the head and neck muscles contributing to chronic migraine, though that application overlaps with the broader FDA-approved use of botulinum toxin for chronic migraine rather than being purely a trigger point treatment.

For most people dealing with run-of-the-mill myofascial trigger points, the conversation will be between a local anesthetic injection, dry needling, or a combination of local anesthetic with a corticosteroid. Given the current state of the evidence, the steroid is the component with the weakest justification for being in the syringe, and pain-medicine guidelines reflect that assessment. If your clinician includes one, it is not harmful in a single dose, but it is worth understanding that the steroid is contributing less to your relief than you might assume.